Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China
Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy. Methods: The DALY is the sum of...
Gespeichert in:
Veröffentlicht in: | Epilepsia (Copenhagen) 2006-12, Vol.47 (12), p.2032-2037 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2037 |
---|---|
container_issue | 12 |
container_start_page | 2032 |
container_title | Epilepsia (Copenhagen) |
container_volume | 47 |
creator | Ding, Ding Hong, Zhen Wang, Wen‐zhi Wu, Jian‐zhong De Boer, Hanneke M. Prilipko, Leonid Sander, Josemir W. |
description | Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy.
Methods: The DALY is the sum of the number of years of survival with disability (Years Lived with Disability, YLD) and the number of years lost because of premature mortality (Years of Life Lost, YLL). We calculated the YLD based on the prevalence survey of epilepsy among 66,393 people sampled in Heilongjiang, Henan, Jiangsu, Ningxia, Shanghai, and Shanxi provinces in 2000. The epilepsy mortality data from Chinese literature provided the YLL due to epilepsy. We applied sensitivity analysis to evaluate the influence of uncertainty on the epilepsy mortality value and disability weight in the study.
Results: In 2000, epilepsy caused 1.83 and 2.48 DALY lost per 1,000 population in Henan and Ningxia province, which had the lowest and the highest DALY lost among the six study areas. Overall, epilepsy caused 1.41 YLLs and 0.67 YLDs per 1,000 population; thus the DALYs lost because of epilepsy was 2.08 per 1,000 population, representing the epilepsy disease burden in rural China.
Conclusions: The DALY measure, which includes the extent of disability from epilepsy, provides a useful tool for the epilepsy disease burden assessment. The disease burden of epilepsy in China is considered higher than previous estimations. |
doi_str_mv | 10.1111/j.1528-1167.2006.00802.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68284714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68284714</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4772-4f669c29d24ad0c4fd258e4b244035f7de822a2b14b76cfcc7c68d9f757593523</originalsourceid><addsrcrecordid>eNqNkUFv1DAQhS0EotvCX0C-wC1h7DixI3FZtttSaSUQggMSkuXYY-pVNrvYidr8-ybsqj0WX2xpvvGbeY8QyiBn0_m4zVnJVcZYJXMOUOUACnh-_4IsHgsvyQKAFVldKjgj5yltAUBWsnhNzpjkwCTAgvxepoQphe4P7W-RXoaEJiH9PESHHb0ckPZ7uj6EFg9ppM04E6YJbehHunTbIfXo6CZ4pL_QRBo6-n2IpqWr29CZN-SVN23Ct6f7gvy8Wv9Yfck2X69vVstNZoWUPBO-qmrLa8eFcWCFd7xUKBouBBSllw4V54Y3TDSyst5aaSvlai9LWdZFyYsL8uH47yHu_w6Yer0LyWLbmg73Q9KV4kpIJp4FOdSTtJITqI6gjfuUInp9iGFn4qgZ6DkCvdWz03p2Ws8R6H8R6Pup9d1JY2h26J4aT55PwPsTYJI1rY-msyE9cUrwaa152E9H7m5yf_zvAfT62830KB4AHYSf4Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20925887</pqid></control><display><type>article</type><title>Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>IngentaConnect Free/Open Access Journals</source><source>Alma/SFX Local Collection</source><creator>Ding, Ding ; Hong, Zhen ; Wang, Wen‐zhi ; Wu, Jian‐zhong ; De Boer, Hanneke M. ; Prilipko, Leonid ; Sander, Josemir W.</creator><creatorcontrib>Ding, Ding ; Hong, Zhen ; Wang, Wen‐zhi ; Wu, Jian‐zhong ; De Boer, Hanneke M. ; Prilipko, Leonid ; Sander, Josemir W.</creatorcontrib><description>Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy.
Methods: The DALY is the sum of the number of years of survival with disability (Years Lived with Disability, YLD) and the number of years lost because of premature mortality (Years of Life Lost, YLL). We calculated the YLD based on the prevalence survey of epilepsy among 66,393 people sampled in Heilongjiang, Henan, Jiangsu, Ningxia, Shanghai, and Shanxi provinces in 2000. The epilepsy mortality data from Chinese literature provided the YLL due to epilepsy. We applied sensitivity analysis to evaluate the influence of uncertainty on the epilepsy mortality value and disability weight in the study.
Results: In 2000, epilepsy caused 1.83 and 2.48 DALY lost per 1,000 population in Henan and Ningxia province, which had the lowest and the highest DALY lost among the six study areas. Overall, epilepsy caused 1.41 YLLs and 0.67 YLDs per 1,000 population; thus the DALYs lost because of epilepsy was 2.08 per 1,000 population, representing the epilepsy disease burden in rural China.
Conclusions: The DALY measure, which includes the extent of disability from epilepsy, provides a useful tool for the epilepsy disease burden assessment. The disease burden of epilepsy in China is considered higher than previous estimations.</description><identifier>ISSN: 0013-9580</identifier><identifier>EISSN: 1528-1167</identifier><identifier>DOI: 10.1111/j.1528-1167.2006.00802.x</identifier><identifier>PMID: 17201700</identifier><identifier>CODEN: EPILAK</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adolescent ; Adult ; Aged ; Anticonvulsants. Antiepileptics. Antiparkinson agents ; Biological and medical sciences ; Cause of Death ; Child ; Child, Preschool ; China - epidemiology ; Cost of Illness ; Disability Adjusted Life Year (DALY) ; Disability Evaluation ; Disease burden ; Epilepsy ; Epilepsy - diagnosis ; Epilepsy - epidemiology ; Epilepsy - mortality ; Female ; Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy ; Humans ; Male ; Medical sciences ; Metabolic diseases ; Metals (hemochromatosis...) ; Middle Aged ; Mortality ; Nervous system (semeiology, syndromes) ; Neurology ; Neuropharmacology ; Other metabolic disorders ; Outcome Assessment (Health Care) ; Pharmacology. Drug treatments ; Prevalence ; Quality-Adjusted Life Years ; Rural Population - statistics & numerical data ; Survival Analysis</subject><ispartof>Epilepsia (Copenhagen), 2006-12, Vol.47 (12), p.2032-2037</ispartof><rights>2007 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4772-4f669c29d24ad0c4fd258e4b244035f7de822a2b14b76cfcc7c68d9f757593523</citedby><cites>FETCH-LOGICAL-c4772-4f669c29d24ad0c4fd258e4b244035f7de822a2b14b76cfcc7c68d9f757593523</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1528-1167.2006.00802.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1528-1167.2006.00802.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,1428,27905,27906,45555,45556,46390,46814</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18425934$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17201700$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ding, Ding</creatorcontrib><creatorcontrib>Hong, Zhen</creatorcontrib><creatorcontrib>Wang, Wen‐zhi</creatorcontrib><creatorcontrib>Wu, Jian‐zhong</creatorcontrib><creatorcontrib>De Boer, Hanneke M.</creatorcontrib><creatorcontrib>Prilipko, Leonid</creatorcontrib><creatorcontrib>Sander, Josemir W.</creatorcontrib><title>Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China</title><title>Epilepsia (Copenhagen)</title><addtitle>Epilepsia</addtitle><description>Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy.
Methods: The DALY is the sum of the number of years of survival with disability (Years Lived with Disability, YLD) and the number of years lost because of premature mortality (Years of Life Lost, YLL). We calculated the YLD based on the prevalence survey of epilepsy among 66,393 people sampled in Heilongjiang, Henan, Jiangsu, Ningxia, Shanghai, and Shanxi provinces in 2000. The epilepsy mortality data from Chinese literature provided the YLL due to epilepsy. We applied sensitivity analysis to evaluate the influence of uncertainty on the epilepsy mortality value and disability weight in the study.
Results: In 2000, epilepsy caused 1.83 and 2.48 DALY lost per 1,000 population in Henan and Ningxia province, which had the lowest and the highest DALY lost among the six study areas. Overall, epilepsy caused 1.41 YLLs and 0.67 YLDs per 1,000 population; thus the DALYs lost because of epilepsy was 2.08 per 1,000 population, representing the epilepsy disease burden in rural China.
Conclusions: The DALY measure, which includes the extent of disability from epilepsy, provides a useful tool for the epilepsy disease burden assessment. The disease burden of epilepsy in China is considered higher than previous estimations.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anticonvulsants. Antiepileptics. Antiparkinson agents</subject><subject>Biological and medical sciences</subject><subject>Cause of Death</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>China - epidemiology</subject><subject>Cost of Illness</subject><subject>Disability Adjusted Life Year (DALY)</subject><subject>Disability Evaluation</subject><subject>Disease burden</subject><subject>Epilepsy</subject><subject>Epilepsy - diagnosis</subject><subject>Epilepsy - epidemiology</subject><subject>Epilepsy - mortality</subject><subject>Female</subject><subject>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Metabolic diseases</subject><subject>Metals (hemochromatosis...)</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Nervous system (semeiology, syndromes)</subject><subject>Neurology</subject><subject>Neuropharmacology</subject><subject>Other metabolic disorders</subject><subject>Outcome Assessment (Health Care)</subject><subject>Pharmacology. Drug treatments</subject><subject>Prevalence</subject><subject>Quality-Adjusted Life Years</subject><subject>Rural Population - statistics & numerical data</subject><subject>Survival Analysis</subject><issn>0013-9580</issn><issn>1528-1167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUFv1DAQhS0EotvCX0C-wC1h7DixI3FZtttSaSUQggMSkuXYY-pVNrvYidr8-ybsqj0WX2xpvvGbeY8QyiBn0_m4zVnJVcZYJXMOUOUACnh-_4IsHgsvyQKAFVldKjgj5yltAUBWsnhNzpjkwCTAgvxepoQphe4P7W-RXoaEJiH9PESHHb0ckPZ7uj6EFg9ppM04E6YJbehHunTbIfXo6CZ4pL_QRBo6-n2IpqWr29CZN-SVN23Ct6f7gvy8Wv9Yfck2X69vVstNZoWUPBO-qmrLa8eFcWCFd7xUKBouBBSllw4V54Y3TDSyst5aaSvlai9LWdZFyYsL8uH47yHu_w6Yer0LyWLbmg73Q9KV4kpIJp4FOdSTtJITqI6gjfuUInp9iGFn4qgZ6DkCvdWz03p2Ws8R6H8R6Pup9d1JY2h26J4aT55PwPsTYJI1rY-msyE9cUrwaa152E9H7m5yf_zvAfT62830KB4AHYSf4Q</recordid><startdate>200612</startdate><enddate>200612</enddate><creator>Ding, Ding</creator><creator>Hong, Zhen</creator><creator>Wang, Wen‐zhi</creator><creator>Wu, Jian‐zhong</creator><creator>De Boer, Hanneke M.</creator><creator>Prilipko, Leonid</creator><creator>Sander, Josemir W.</creator><general>Blackwell Publishing Inc</general><general>Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200612</creationdate><title>Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China</title><author>Ding, Ding ; Hong, Zhen ; Wang, Wen‐zhi ; Wu, Jian‐zhong ; De Boer, Hanneke M. ; Prilipko, Leonid ; Sander, Josemir W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4772-4f669c29d24ad0c4fd258e4b244035f7de822a2b14b76cfcc7c68d9f757593523</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anticonvulsants. Antiepileptics. Antiparkinson agents</topic><topic>Biological and medical sciences</topic><topic>Cause of Death</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>China - epidemiology</topic><topic>Cost of Illness</topic><topic>Disability Adjusted Life Year (DALY)</topic><topic>Disability Evaluation</topic><topic>Disease burden</topic><topic>Epilepsy</topic><topic>Epilepsy - diagnosis</topic><topic>Epilepsy - epidemiology</topic><topic>Epilepsy - mortality</topic><topic>Female</topic><topic>Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Metabolic diseases</topic><topic>Metals (hemochromatosis...)</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Nervous system (semeiology, syndromes)</topic><topic>Neurology</topic><topic>Neuropharmacology</topic><topic>Other metabolic disorders</topic><topic>Outcome Assessment (Health Care)</topic><topic>Pharmacology. Drug treatments</topic><topic>Prevalence</topic><topic>Quality-Adjusted Life Years</topic><topic>Rural Population - statistics & numerical data</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ding, Ding</creatorcontrib><creatorcontrib>Hong, Zhen</creatorcontrib><creatorcontrib>Wang, Wen‐zhi</creatorcontrib><creatorcontrib>Wu, Jian‐zhong</creatorcontrib><creatorcontrib>De Boer, Hanneke M.</creatorcontrib><creatorcontrib>Prilipko, Leonid</creatorcontrib><creatorcontrib>Sander, Josemir W.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Epilepsia (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ding, Ding</au><au>Hong, Zhen</au><au>Wang, Wen‐zhi</au><au>Wu, Jian‐zhong</au><au>De Boer, Hanneke M.</au><au>Prilipko, Leonid</au><au>Sander, Josemir W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China</atitle><jtitle>Epilepsia (Copenhagen)</jtitle><addtitle>Epilepsia</addtitle><date>2006-12</date><risdate>2006</risdate><volume>47</volume><issue>12</issue><spage>2032</spage><epage>2037</epage><pages>2032-2037</pages><issn>0013-9580</issn><eissn>1528-1167</eissn><coden>EPILAK</coden><abstract>Purpose: To demonstrate the application of Disability Adjusted Life Year (DALY) as an aid in health outcome measures to evaluate the epilepsy disease burden in rural China and to provide Chinese data to achieve a better understanding of disease burden due to epilepsy.
Methods: The DALY is the sum of the number of years of survival with disability (Years Lived with Disability, YLD) and the number of years lost because of premature mortality (Years of Life Lost, YLL). We calculated the YLD based on the prevalence survey of epilepsy among 66,393 people sampled in Heilongjiang, Henan, Jiangsu, Ningxia, Shanghai, and Shanxi provinces in 2000. The epilepsy mortality data from Chinese literature provided the YLL due to epilepsy. We applied sensitivity analysis to evaluate the influence of uncertainty on the epilepsy mortality value and disability weight in the study.
Results: In 2000, epilepsy caused 1.83 and 2.48 DALY lost per 1,000 population in Henan and Ningxia province, which had the lowest and the highest DALY lost among the six study areas. Overall, epilepsy caused 1.41 YLLs and 0.67 YLDs per 1,000 population; thus the DALYs lost because of epilepsy was 2.08 per 1,000 population, representing the epilepsy disease burden in rural China.
Conclusions: The DALY measure, which includes the extent of disability from epilepsy, provides a useful tool for the epilepsy disease burden assessment. The disease burden of epilepsy in China is considered higher than previous estimations.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>17201700</pmid><doi>10.1111/j.1528-1167.2006.00802.x</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0013-9580 |
ispartof | Epilepsia (Copenhagen), 2006-12, Vol.47 (12), p.2032-2037 |
issn | 0013-9580 1528-1167 |
language | eng |
recordid | cdi_proquest_miscellaneous_68284714 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; IngentaConnect Free/Open Access Journals; Alma/SFX Local Collection |
subjects | Adolescent Adult Aged Anticonvulsants. Antiepileptics. Antiparkinson agents Biological and medical sciences Cause of Death Child Child, Preschool China - epidemiology Cost of Illness Disability Adjusted Life Year (DALY) Disability Evaluation Disease burden Epilepsy Epilepsy - diagnosis Epilepsy - epidemiology Epilepsy - mortality Female Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy Humans Male Medical sciences Metabolic diseases Metals (hemochromatosis...) Middle Aged Mortality Nervous system (semeiology, syndromes) Neurology Neuropharmacology Other metabolic disorders Outcome Assessment (Health Care) Pharmacology. Drug treatments Prevalence Quality-Adjusted Life Years Rural Population - statistics & numerical data Survival Analysis |
title | Assessing the Disease Burden Due to Epilepsy by Disability Adjusted Life Year in Rural China |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A50%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Assessing%20the%20Disease%20Burden%20Due%20to%20Epilepsy%20by%20Disability%20Adjusted%20Life%20Year%20in%20Rural%20China&rft.jtitle=Epilepsia%20(Copenhagen)&rft.au=Ding,%20Ding&rft.date=2006-12&rft.volume=47&rft.issue=12&rft.spage=2032&rft.epage=2037&rft.pages=2032-2037&rft.issn=0013-9580&rft.eissn=1528-1167&rft.coden=EPILAK&rft_id=info:doi/10.1111/j.1528-1167.2006.00802.x&rft_dat=%3Cproquest_cross%3E68284714%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20925887&rft_id=info:pmid/17201700&rfr_iscdi=true |